HIV and Hepatitis.com Coverage of
DIGESTIVE DISEASE WEEK (DDW 2008)
May 17 - 22, 2008, San Diego, California
Sign up to receive
our twice-weekly
e-Newsletter
The material posted on HIV and Hepatitis.com about DDW 2008 is not approved
by nor is it a part of DDW 2008.


 Hepatitis C Articles
Chronic Hepatitis C May Contribute to an Elevated Risk of Bone Fractures in Postmenopausal Women
Pegylated Interferon Alfa-2a (Pegasys) Continues to Suppress HBV, but Adding Adefovir (Hepsera) Provides No Extra Benefit in PEG for B Trial
Sustained Virological Response to Pegylated Interferon Alfa-2b (PegIntron) with or without Ribavirin Predicts Continued Response through 5 Years
Very Early Response to Interferon-based Therapy for Hepatitis C Is Apparent within the First 24 Hours
Significance of Transient HCV Viral Load "Blips" during Interferon-based Therapy for Chronic Hepatitis C
Antiviral Activity, Pharmacodynamics, and Quality of Life in Genotype 1 Hepatitis C Patients Treated with Albinterferon (Albuferon)
Symptoms and Response to Interferon plus Ribavirin in Children with Chronic Hepatitis C
Response to Interferon-based Therapy in Hispanic Patients with Chronic Hepatitis C
Platelet Count Is a Strong Predictor of Sustained Response to Pegylated Interferon/ribavirin in Prior Non-Responders (EPIC 3)
Amino Acid Substitutions in HCV Core Region Predict Poor Response to Pegylated Interferon/ribavirin in Genotype 1b Patients
HCV May Inhibit HBV Replication in HCV-HBV Coinfected Patients
Medical, Psychiatric, and Substance Use Co-morbidities in HCV Monoinfected and HIV-HCV Coinfected Veterans
 Hepatitis B Articles
High Maternal HBV Viral Load, but Not HBeAg Status, Predicts Mother-to-child Hepatitis B Transmission - 5/30/08
Response to Pegylated Interferon in Adolescents with Chronic Hepatitis B
HCV May Inhibit HBV Replication in HCV-HBV Coinfected Patients
 HIV-HCV and HIV-HBV Coinfection Articles
Long-term Alcohol Abuse Is Linked to Worse Liver Fibrosis in HIV Positive Veterans with or without HCV Coinfection
Sexual Transmission of HCV and Triple Infection with HBV Predict Spontaneous HCV Clearance in HIV-HCV Coinfected Individuals
HCV May Inhibit HBV Replication in HCV-HBV Coinfected Patients
Medical, Psychiatric, and Substance Use Co-morbidities in HCV Monoinfected and HIV-HCV Coinfected Veterans
Many HIV-HCV Coinfected Patients Are Not Evaluated for Hepatitis C Management
 LIbrary of Slides and Posters
Results from the EPIC3 Program: Platelet Counts Are Strong Predictors of Sustained Viral Response (SVR) in the Re-Treatment of Previous Interferon/Ribavirin Non-Responders (NR)
T Poynard and others. DDW 2008.
Clearance of HCV at 5-Year Follow-up for Peginterferon alfa-2b ± Ribavirin Is Predicted by Sustained Virologic Response at 24 Weeks Post-Treatment
K Lindsay and others. DDW 2008.
Sustained Virologic Response and Relapse Rates With Peginterferon alfa-2b plus Ribavirin in Clinical Trials Are Comparable to Those in Community-Based Studies
M Manns and others. DDW 2008.
Rapid Virologic Response to Peginterferon alfa and Ribavirin Treatment of Chronic Hepatitis C Predicts Sustained Virologic Response and Relapse
F Poordad and others. DDW 2008.
Clearance of HCV in Children at 5-Year Follow-up Is Predicted by Sustained Virologic Response at 24 Weeks Post Treatment With Interferon alfa-2b Plus Ribavirin
D Kelly and others. DDW 2008.
Efficacy of Entecavir in Nucleoside-naïve Patients with Mildly Elevated ALT
S Gordon and others. DDW 2008.

 

Sponsors







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DDW 2008 Conference Coverage by HIV and Hepatitis.com
Highlights of DDW 2008 Conference Coverage by HIV and Hepatitis.com
DDW 2008 Conference Coverage by HIV and Hepatitis.com
Highlights of DDW 2008 Conference Coverage by HIV and Hepatitis.com